Cargando…

Comprehensive molecular characterization of a rare case of Philadelphia chromosome–positive acute myeloid leukemia

The Philadelphia chromosome (Ph) resulting from the t(9;22) translocation generates the oncogenic BCR::ABL1 fusion protein that is most commonly associated with chronic myeloid leukemia (CML) and Ph-positive (Ph+) acute lymphoblastic leukemia (ALL). There are also rare instances of patients (≤1%) wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rosenberg, Mara W., Savage, Samantha L., Eide, Christopher A., Reister Schultz, Anna, Cook, Rachel J., Press, Richard D., Rempfer, Carole, Eickelberg, Garrett, Wilmot, Beth, McWeeney, Shannon K., Tyner, Jeffrey W., Druker, Brian J., Tognon, Cristina E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory Press 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632359/ https://www.ncbi.nlm.nih.gov/pubmed/36307214 http://dx.doi.org/10.1101/mcs.a006218

Ejemplares similares

HitWalker: variant prioritization for personalized functional cancer genomics
por: Bottomly, Daniel, et al.
Publicado: (2013)

Characterization of the leukemogenic potential of distal cytoplasmic CSF3R truncation and missense mutations
por: Zhang, Haijiao, et al.
Publicado: (2017)

Luxeptinib (CG-806) Targets FLT3 and Clusters of Kinases Operative in Acute Myeloid Leukemia
por: Rice, William G., et al.
Publicado: (2022)

Comparison of methods to identify aberrant expression patterns in individual patients: augmenting our toolkit for precision medicine
por: Bottomly, Daniel, et al.
Publicado: (2013)

ERBB2/HER2 mutations are transforming and therapeutically targetable in leukemia
por: Joshi, Sunil K., et al.
Publicado: (2020)

Associating drug sensitivity with differentiation status identifies effective combinations for acute myeloid leukemia
por: Kurtz, Stephen E., et al.
Publicado: (2022)

Clinical resistance to crenolanib in acute myeloid leukemia due to diverse molecular mechanisms
por: Zhang, Haijiao, et al.
Publicado: (2019)

A genome-wide CRISPR screen identifies regulators of MAPK and MTOR pathways that mediate resistance to sorafenib in acute myeloid leukemia
por: Damnernsawad, Alisa, et al.
Publicado: (2020)

plethy: management of whole body plethysmography data in R
por: Bottomly, Daniel, et al.
Publicado: (2015)

HitWalker2: visual analytics for precision medicine and beyond
por: Bottomly, Daniel, et al.
Publicado: (2016)

Genomic markers of midostaurin drug sensitivity in FLT3 mutated and FLT3 wild-type acute myeloid leukemia patients
por: Rosenberg, Mara W., et al.
Publicado: (2020)

Comparison and validation of the 2022 European LeukemiaNet guidelines in acute myeloid leukemia
por: Lachowiez, Curtis A., et al.
Publicado: (2022)

Immune cell proportions correlate with clinicogenomic features and ex vivo drug responses in acute myeloid leukemia
por: Romine, Kyle A., et al.
Publicado: (2023)

Reversible suppression of T cell function in the bone marrow microenvironment of acute myeloid leukemia
por: Lamble, Adam J., et al.
Publicado: (2020)

Durable Disease Control with MEK Inhibition in a Patient with NRAS-mutated Atypical Chronic Myeloid Leukemia
por: Khanna, Vishesh, et al.
Publicado: (2015)

Predicting response to BET inhibitors using computational modeling: A BEAT AML project study
por: Drusbosky, Leylah M., et al.
Publicado: (2019)

Splicing landscape of the eight collaborative cross founder strains
por: Zheng, Christina L, et al.
Publicado: (2015)

A Single-Cell Approach to the Elusive Latent Human Cytomegalovirus Transcriptome
por: Goodrum, Felicia, et al.
Publicado: (2018)

Targeting of colony-stimulating factor 1 receptor (CSF1R) in the CLL microenvironment yields antineoplastic activity in primary patient samples
por: Edwards V, David K., et al.
Publicado: (2018)

Androgen Receptor Promotes Ligand-Independent Prostate Cancer Progression through c-Myc Upregulation
por: Gao, Lina, et al.
Publicado: (2013)

The genetics of gene expression in complex mouse crosses as a tool to study the molecular underpinnings of behavior traits
por: Hitzemann, Robert, et al.
Publicado: (2013)

Lentiviral-Driven Discovery of Cancer Drug Resistance Mutations
por: Yenerall, Paul, et al.
Publicado: (2021)

Significant clinical response to JAK1/2 inhibition in a patient with CSF3R-T618I-positive atypical chronic myeloid leukemia
por: Dao, Kim-Hien T., et al.
Publicado: (2014)

Discovery and functional characterization of a germline, CSF2RB-activating mutation in leukemia
por: Watanabe-Smith, Kevin, et al.
Publicado: (2016)

Localization of TFIIB binding regions using serial analysis of chromatin occupancy
por: Yochum, Gregory S, et al.
Publicado: (2007)

Quantitative Trait Locus Analysis: Multiple Cross and Heterogeneous Stock Mapping
por: Hitzemann, Robert, et al.
Publicado: (2008)

On the Relation of the Parasitic Protozoa to Each Other and to Human Disease
por: McWeeney, E. J.
Publicado: (1905)

DNA methylation epitypes highlight underlying developmental and disease pathways in acute myeloid leukemia
por: Giacopelli, Brian, et al.
Publicado: (2021)

Functional Genomic Landscape of Acute Myeloid Leukemia
por: Tyner, Jeffrey W., et al.
Publicado: (2018)

A systems framework for vaccine design
por: Mooney, Michael, et al.
Publicado: (2013)

Visualization of drug target interactions in the contexts of pathways and networks with ReactomeFIViz
por: Blucher, Aurora S., et al.
Publicado: (2019)

Occupancy Classification of Position Weight Matrix-Inferred Transcription Factor Binding Sites
por: Wright, Hollis, et al.
Publicado: (2011)

Identification of β-catenin binding regions in colon cancer cells using ChIP-Seq
por: Bottomly, Daniel, et al.
Publicado: (2010)

Multi-omic network signatures of disease
por: Gibbs, David L., et al.
Publicado: (2014)

Use of semantic workflows to enhance transparency and reproducibility in clinical omics
por: Zheng, Christina L., et al.
Publicado: (2015)

How I read an article that uses machine learning methods
por: Nazha, Aziz, et al.
Publicado: (2023)

Aurora A kinase as a target for therapy in TCF3-HLF rearranged acute lymphoblastic leukemia
por: Leonard, Jessica, et al.
Publicado: (2021)

Cells on the move in Philadelphia
por: Sixt, Michael, et al.
Publicado: (2011)

The combination of NPM1, DNMT3A, and IDH1/2 mutations leads to inferior overall survival in AML
por: Dunlap, Jennifer B., et al.
Publicado: (2019)

Functional RNAi screen targeting cytokine and growth factor receptors reveals oncorequisite role for interleukin-2 gamma receptor in JAK3 mutation-positive leukemia
por: Agarwal, Anupriya, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_opljefi2k49qhsffqk3hoplud4